All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F23%3A00078352" target="_blank" >RIV/65269705:_____/23:00078352 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/23:00131614

  • Result on the web

    <a href="https://www.frontiersin.org/articles/10.3389/fcvm.2023.1243531/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fcvm.2023.1243531/full</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3389/fcvm.2023.1243531" target="_blank" >10.3389/fcvm.2023.1243531</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future

  • Original language description

    Treatment of malignant lymphoma has for years been represented by many cardiotoxic agents especially anthracyclines, cyclophosphamide, and thoracic irradiation. Although they are in clinical practice for decades, the precise mechanism of cardiotoxicity and effective prevention is still part of the research. At this article we discuss most routinely used anti-cancer drugs in chemotherapeutic regiments for malignant lymphoma with the focus on novel insight on molecular mechanisms of cardiotoxicity. Understanding toxicity at molecular levels may unveil possible targets of cardioprotective supportive therapy or optimization of current therapeutic protocols. Additionally, we review novel specific targeted therapy and its challenges in cardio-oncology.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Frontiers in Cardiovascular Medicine

  • ISSN

    2297-055X

  • e-ISSN

    2297-055X

  • Volume of the periodical

    10

  • Issue of the periodical within the volume

    2023

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    16

  • Pages from-to

    1243531

  • UT code for WoS article

    001064769300001

  • EID of the result in the Scopus database

    2-s2.0-85170709984